We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Oxford Biomedica | AQSE:OXB.GB | Aquis Stock Exchange | Ordinary Share | GB00BDFBVT43 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 217.50 | 210.00 | 225.00 | 217.50 | 217.50 | 217.50 | 0.00 | 06:56:52 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
TIDMOXB
RNS Number : 9513U
Oxford Biomedica PLC
24 January 2017
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
Hot Features
Premium
1 Issuer Oxford BioMedica PLC
------ ------------------------ ----------------------------------
2 Reason for notification Notification relates to DTR
3.1.2R
------ ------------------------ ----------------------------------
3 Name of PDMR Martin Diggle
------ ------------------------ ----------------------------------
4 Connected person Notification relates to following
connected persons:
Vulpes Life Sciences Fund
------ ------------------------ ----------------------------------
5 Notification Notification in respect of
in respect of holdings of persons in 4 above
------ ------------------------ ----------------------------------
6 Description Oxford BioMedica PLC ordinary
of shares shares of 1p each
------ ------------------------ ----------------------------------
7 Name of registered Vulpes Life Sciences Fund
shareholders - 549,132,000 shares
and number of Vulpes Testudo Fund - 33,333,333
shares shares
------ ------------------------ ----------------------------------
8 Nature of transaction Acquisition
------ ------------------------ ----------------------------------
9 Number of shares Vulpes Life Sciences Fund
acquired - 600,000 shares
------ ------------------------ ----------------------------------
10 Percentage of Vulpes Life Sciences Fund
issued class - 0.02%
acquired
------ ------------------------ ----------------------------------
11 Shares disposed N/A
------ ------------------------ ----------------------------------
12 Percentage of N/A
issued class
disposed
------ ------------------------ ----------------------------------
13/14 Price per share Vulpes Life Sciences Fund
of transactions, 600,000 shares @ GBP0.0422
and date , 23 Jan 2017
------ ------------------------ ----------------------------------
15 Total holding Vulpes Life Sciences Fund
following notification - 549,732,000 shares
and total percentage 17.80%
holding following Vulpes Testudo Fund - 33,333,333
notification shares
1.08%
------ ------------------------ ----------------------------------
16 Date issuer 24 Jan 2017
informed
------ ------------------------ ----------------------------------
23 Any additional None
information
------ ------------------------ ----------------------------------
24 Contact name T. Watts, Chief Financial
and telephone Officer
number Oxford BioMedica
+44 (0)1865 783000
------ ------------------------ ----------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHGCGDBCDDBGRS
(END) Dow Jones Newswires
January 24, 2017 04:31 ET (09:31 GMT)
1 Year Oxford Biomedica Chart |
1 Month Oxford Biomedica Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
